Skip to main content
Skip to content
Case File
sd-10-EFTA01374120Dept. of JusticeOther

EFTA Document EFTA01374120

AGP LP 519 Alpha Group Caudal Paul Barren Xanthus Fund and the Global Growth Fund. OAM is the managing member and Alkeon is a non-managing member of AAMM and AAM. ALPRO Alkeon acts as investment manager to ALPRO Growth Fund, plc ("ALPRO Growth") an open- ended variable capital company authorized as designated company under Part XIII of the Companies Act, 1990 of Ireland and supervised by the Central Bank of Ireland. ALPRO is manager of ALPRO Growth. MS UCITs Alkeon acts as investment man

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01374120
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

AGP LP 519 Alpha Group Caudal Paul Barren Xanthus Fund and the Global Growth Fund. OAM is the managing member and Alkeon is a non-managing member of AAMM and AAM. ALPRO Alkeon acts as investment manager to ALPRO Growth Fund, plc ("ALPRO Growth") an open- ended variable capital company authorized as designated company under Part XIII of the Companies Act, 1990 of Ireland and supervised by the Central Bank of Ireland. ALPRO is manager of ALPRO Growth. MS UCITs Alkeon acts as investment man

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
AGP LP 519 Alpha Group Caudal Paul Barren Xanthus Fund and the Global Growth Fund. OAM is the managing member and Alkeon is a non-managing member of AAMM and AAM. ALPRO Alkeon acts as investment manager to ALPRO Growth Fund, plc ("ALPRO Growth") an open- ended variable capital company authorized as designated company under Part XIII of the Companies Act, 1990 of Ireland and supervised by the Central Bank of Ireland. ALPRO is manager of ALPRO Growth. MS UCITs Alkeon acts as investment manager for MS Alkeon UCITs Fund ("MS UCITs), a sub-fund of FundLogic Alternatives plc, a company incorporated with limited liability as an open-ended investment company with variable capital under the laws of Ireland and authorized by the Central Bank of Ireland. Insurance Series Alkeon acts as sub-adviser to Alkeon Insurance Growth Fund Series Interests of the SALI Multi- Series Fund, L.P., a Delaware series limited partnership (the "Insurance Series"). SALI and SALI Fund Partners, LLC are the investment manager and general partner, respectively, of the SALI Multi-Series Fund, L.P. General Information about Alkeon's Advisory Business Alkeon invests principally, but not solely, in long or short positions of publicly-traded and private companies in global markets on behalf of the funds it manages, but is authorized to enter into any type of investment transaction that it deems appropriate under the terms of the offering documents for those funds. The investors in the funds that Alkeon manages have no opportunity to select or evaluate any fund investments or strategies. Alkeon selects all fund investments and strategies. Alkeon's discretionary authority is limited, however, as described in Item 16. Item 5. Fees and Compensation Alkeon's compensation is negotiable and varies, but typically, it receives an asset-based fee from each fund based on a percentage of that fund's assets under management. In addition, Alkeon, or an affiliate of Alkeon, also typically receives an annual, semi-annual or quarterly incentive fee/allocation based on the amount of the net realized and unrealized profits attributable to an investor for that period, adjusted for net losses incurred by such investor in prior periods. The asset-based fee and incentive fee/allocation are charged to client accounts and investors in the manners described below. Alkeon complies with Rule 205-3 under the Investment Advisers Act of 1940, to the extent required by applicable law. Incentive fees/allocations may create an incentive for Alkeon to make more risky and speculative investments than it would otherwise make. 5 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0068660 CONFIDENTIAL SDNY_GM_00214844 EFTA01374120

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.